Disetronic plans to go public in summer
This article was originally published in Clinica
Swiss drug delivery manufacturer Disetronic intends to float on the Zurich stock exchange this summer. Around 30% of the company will be offered to the public, with some 20% sold by two Swiss banks and the rest issued as new shares by Disetronic. The company will use the proceeds to extend the sterile disposable products business and accelerate expansion into new international markets. After the float, Disetronic will continue to be controlled by majority shareholder and CEO Willy Michel.